$CCCC
C4 Therapeutics, Inc.

2022 Q3 Form 10-Q Financial Statement

#000162828022020886 Filed on August 04, 2022

View on sec.gov

Income Statement

Concept 2022 Q3 2022 Q2 2022 Q1
Revenue $6.754M $13.83M $7.654M
YoY Change -20.54% 41.44% 3.01%
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin $9.579M $9.895M $12.82M
YoY Change 13.33% 14.91% 73.01%
% of Gross Profit
Research & Development $29.66M $31.32M $26.20M
YoY Change 22.06% 34.51% 27.66%
% of Gross Profit
Depreciation & Amortization $415.0K $435.0K $305.0K
YoY Change 25.76% 12.11% -32.37%
% of Gross Profit
Operating Expenses $39.24M $41.22M $39.02M
YoY Change 19.81% 29.22% 39.69%
Operating Profit -$32.49M -$27.38M -$31.37M
YoY Change 33.95% 23.82% 52.95%
Interest Expense $530.0K -$28.00K -$251.0K
YoY Change -223.54% -93.97% -45.43%
% of Operating Profit
Other Income/Expense, Net $530.0K -$28.00K -$251.0K
YoY Change -223.54% -93.97% -45.67%
Pretax Income -$31.96M -$27.41M -$31.62M
YoY Change 29.47% 21.4% 50.78%
Income Tax $0.00 $0.00
% Of Pretax Income
Net Earnings -$31.96M -$27.41M -$31.62M
YoY Change 29.47% 21.4% 50.78%
Net Earnings / Revenue -473.17% -198.15% -413.12%
Basic Earnings Per Share -$0.65 -$0.56 -$0.65
Diluted Earnings Per Share -$0.65 -$0.56 -$648.8K
COMMON SHARES
Basic Shares Outstanding 48.91M shares 48.82M shares 48.74M
Diluted Shares Outstanding 48.92M shares 48.82M shares 48.73M shares

Balance Sheet

Concept 2022 Q3 2022 Q2 2022 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments $313.7M $307.8M $291.2M
YoY Change 92.43% 9.42% 206.35%
Cash & Equivalents $49.55M $57.30M $46.00M
Short-Term Investments $264.1M $250.5M $245.2M
Other Short-Term Assets $10.32M $8.876M $9.999M
YoY Change 91.8% 63.25% 104.06%
Inventory
Prepaid Expenses
Receivables $1.488M $1.709M $1.773M
Other Receivables $0.00 $0.00 $0.00
Total Short-Term Assets $325.5M $318.4M $302.9M
YoY Change -21.06% -33.34% -5.92%
LONG-TERM ASSETS
Property, Plant & Equipment $7.415M $6.337M $3.026M
YoY Change 123.14% 73.47% -24.63%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments $52.36M $90.06M $130.5M
YoY Change -33.04% 174.82% 301.47%
Other Assets $1.313M $1.315M $4.207M
YoY Change -29.18% 127.12% 61.81%
Total Long-Term Assets $136.0M $174.1M $212.5M
YoY Change 42.22% 242.33% 308.67%
TOTAL ASSETS
Total Short-Term Assets $325.5M $318.4M $302.9M
Total Long-Term Assets $136.0M $174.1M $212.5M
Total Assets $461.4M $492.5M $515.5M
YoY Change -9.15% -6.8% 37.83%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $2.370M $4.446M $3.405M
YoY Change -36.72% -0.51% -9.01%
Accrued Expenses $21.31M $17.50M $11.26M
YoY Change 71.19% 62.64% 73.2%
Deferred Revenue $18.13M $22.17M
YoY Change
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due $2.250M $750.0K $750.0K
YoY Change
Total Short-Term Liabilities $45.27M $46.15M $46.99M
YoY Change -7.02% 4.49% 24.79%
LONG-TERM LIABILITIES
Long-Term Debt $9.052M $10.37M $10.19M
YoY Change -14.51% -0.36% -0.36%
Other Long-Term Liabilities $88.94M $91.36M $93.77M
YoY Change 78.4% 59.11% 50.28%
Total Long-Term Liabilities $9.052M $10.37M $10.19M
YoY Change -85.02% -84.71% -0.36%
TOTAL LIABILITIES
Total Short-Term Liabilities $45.27M $46.15M $46.99M
Total Long-Term Liabilities $9.052M $10.37M $10.19M
Total Liabilities $143.3M $147.9M $151.0M
YoY Change 31.27% 32.04% 36.86%
SHAREHOLDERS EQUITY
Retained Earnings -$358.7M -$326.7M -$299.3M
YoY Change 42.28% 43.67% 46.15%
Common Stock $682.3M $675.9M
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $318.2M $344.6M $364.5M
YoY Change
Total Liabilities & Shareholders Equity $461.4M $492.5M $515.5M
YoY Change -9.15% -6.8% 37.83%

Cashflow Statement

Concept 2022 Q3 2022 Q2 2022 Q1
OPERATING ACTIVITIES
Net Income -$31.96M -$27.41M -$31.62M
YoY Change 29.47% 21.4% 50.78%
Depreciation, Depletion And Amortization $415.0K $435.0K $305.0K
YoY Change 25.76% 12.11% -32.37%
Cash From Operating Activities -$28.02M -$22.19M -$26.60M
YoY Change 52.63% 23.26% 6.67%
INVESTING ACTIVITIES
Capital Expenditures -$3.305M -$529.0K $172.0K
YoY Change -29.28% -59.14%
Acquisitions
YoY Change
Other Investing Activities $23.22M $33.76M -$3.832M
YoY Change -123.07% 1.73% -93.75%
Cash From Investing Activities $19.91M $33.23M -$4.004M
YoY Change -119.79% 2.45% -93.51%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 361.0K 259.0K 480.0K
YoY Change -38.18% -99.85% -417.88%
NET CHANGE
Cash From Operating Activities -28.02M -22.19M -26.60M
Cash From Investing Activities 19.91M 33.23M -4.004M
Cash From Financing Activities 361.0K 259.0K 480.0K
Net Change In Cash -7.745M 11.29M -30.12M
YoY Change -93.46% -93.89% -65.31%
FREE CASH FLOW
Cash From Operating Activities -$28.02M -$22.19M -$26.60M
Capital Expenditures -$3.305M -$529.0K $172.0K
Free Cash Flow -$24.72M -$21.67M -$26.77M
YoY Change 34.63% 25.54% 5.57%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
dei Entity Central Index Key
EntityCentralIndexKey
0001662579
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
dei Local Phone Number
LocalPhoneNumber
231-0700
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2022
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q2
dei Amendment Flag
AmendmentFlag
false
dei Document Type
DocumentType
10-Q
dei Document Quarterly Report
DocumentQuarterlyReport
true
dei Document Period End Date
DocumentPeriodEndDate
2022-06-30
dei Document Transition Report
DocumentTransitionReport
false
dei Entity File Number
EntityFileNumber
001-39567
dei Entity Registrant Name
EntityRegistrantName
C4 Therapeutics, Inc.
dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
DE
dei Entity Tax Identification Number
EntityTaxIdentificationNumber
47-5617627
dei Entity Address Address Line1
EntityAddressAddressLine1
490 Arsenal Way
dei Entity Address Address Line2
EntityAddressAddressLine2
Suite 120
dei Entity Address City Or Town
EntityAddressCityOrTown
Watertown
dei Entity Address State Or Province
EntityAddressStateOrProvince
MA
dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
02472
dei City Area Code
CityAreaCode
617
dei Security12b Title
Security12bTitle
Common Stock, $0.0001 par value per share
dei Trading Symbol
TradingSymbol
CCCC
dei Security Exchange Name
SecurityExchangeName
NASDAQ
dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
dei Entity Filer Category
EntityFilerCategory
Large Accelerated Filer
dei Entity Small Business
EntitySmallBusiness
false
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
dei Entity Shell Company
EntityShellCompany
false
CY2022Q3 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
48913765 shares
CY2022Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
57296000 usd
CY2021Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
76124000 usd
CY2022Q2 us-gaap Marketable Securities Current
MarketableSecuritiesCurrent
250484000 usd
CY2021Q4 us-gaap Marketable Securities Current
MarketableSecuritiesCurrent
233155000 usd
CY2022Q2 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
1709000 usd
CY2021Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
5716000 usd
CY2022Q2 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
8876000 usd
CY2021Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
10694000 usd
CY2022Q2 us-gaap Assets Current
AssetsCurrent
318365000 usd
CY2021Q4 us-gaap Assets Current
AssetsCurrent
325689000 usd
CY2022Q2 us-gaap Marketable Securities Noncurrent
MarketableSecuritiesNoncurrent
90057000 usd
CY2021Q4 us-gaap Marketable Securities Noncurrent
MarketableSecuritiesNoncurrent
142200000 usd
CY2022Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
6337000 usd
CY2021Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
3108000 usd
CY2022Q2 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
73122000 usd
CY2021Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
31945000 usd
CY2022Q2 us-gaap Restricted Cash And Cash Equivalents Noncurrent
RestrictedCashAndCashEquivalentsNoncurrent
3279000 usd
CY2021Q4 us-gaap Restricted Cash And Cash Equivalents Noncurrent
RestrictedCashAndCashEquivalentsNoncurrent
3279000 usd
CY2022Q2 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
1315000 usd
CY2021Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
544000 usd
CY2022Q2 us-gaap Assets
Assets
492475000 usd
CY2021Q4 us-gaap Assets
Assets
506765000 usd
CY2022Q2 us-gaap Accounts Payable Current
AccountsPayableCurrent
4446000 usd
CY2021Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
4506000 usd
CY2022Q2 us-gaap Accrued Liabilities And Other Liabilities
AccruedLiabilitiesAndOtherLiabilities
16958000 usd
CY2021Q4 us-gaap Accrued Liabilities And Other Liabilities
AccruedLiabilitiesAndOtherLiabilities
13606000 usd
CY2022Q2 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
22170000 usd
CY2021Q4 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
31800000 usd
CY2022Q2 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
1824000 usd
CY2021Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
1334000 usd
CY2022Q2 us-gaap Long Term Debt Current
LongTermDebtCurrent
750000 usd
CY2021Q4 us-gaap Long Term Debt Current
LongTermDebtCurrent
0 usd
CY2022Q2 us-gaap Liabilities Current
LiabilitiesCurrent
46148000 usd
CY2021Q4 us-gaap Liabilities Current
LiabilitiesCurrent
51246000 usd
CY2022Q2 us-gaap Contract With Customer Liability Noncurrent
ContractWithCustomerLiabilityNoncurrent
17991000 usd
CY2021Q4 us-gaap Contract With Customer Liability Noncurrent
ContractWithCustomerLiabilityNoncurrent
24368000 usd
CY2022Q2 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
73371000 usd
CY2021Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
30777000 usd
CY2022Q2 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
10372000 usd
CY2021Q4 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
10768000 usd
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
16020000 usd
CY2022Q2 us-gaap Liabilities
Liabilities
147882000 usd
CY2021Q4 us-gaap Liabilities
Liabilities
117159000 usd
CY2022Q2 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
usd
CY2021Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
usd
CY2021Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2021Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2021Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10000000 shares
CY2022Q2 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10000000 shares
CY2022Q2 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2021Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2021Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2022Q2 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2022Q2 us-gaap Preferred Stock Value
PreferredStockValue
0 usd
CY2021Q4 us-gaap Preferred Stock Value
PreferredStockValue
0 usd
CY2022Q2 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-28000 usd
CY2022Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2021Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2022Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
150000000 shares
CY2021Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
150000000 shares
CY2022Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
48877652 shares
CY2022Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
48877652 shares
CY2021Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
48688875 shares
CY2021Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
48688875 shares
CY2022Q2 us-gaap Common Stock Value
CommonStockValue
5000 usd
CY2021Q4 us-gaap Common Stock Value
CommonStockValue
5000 usd
CY2022Q2 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
675916000 usd
CY2021Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
658091000 usd
CY2022Q2 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-4581000 usd
CY2021Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-775000 usd
CY2022Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-326747000 usd
CY2021Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-267715000 usd
CY2022Q2 us-gaap Stockholders Equity
StockholdersEquity
344593000 usd
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
389606000 usd
CY2022Q2 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
492475000 usd
CY2021Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
506765000 usd
CY2022Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
13834000 usd
CY2021Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
9781000 usd
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
21488000 usd
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
17207000 usd
CY2022Q2 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
31323000 usd
CY2021Q2 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
23286000 usd
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
57526000 usd
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
43812000 usd
CY2022Q2 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
9895000 usd
CY2021Q2 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
8611000 usd
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
22715000 usd
CY2022Q2 us-gaap Operating Expenses
OperatingExpenses
41218000 usd
CY2021Q2 us-gaap Operating Expenses
OperatingExpenses
31897000 usd
us-gaap Operating Expenses
OperatingExpenses
80241000 usd
us-gaap Operating Expenses
OperatingExpenses
59832000 usd
CY2022Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-27384000 usd
CY2021Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-22116000 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
-58753000 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
-42625000 usd
CY2022Q2 cccc Interest Expense And Amortization Of Long Term Debt Related Party
InterestExpenseAndAmortizationOfLongTermDebtRelatedParty
534000 usd
CY2021Q2 cccc Interest Expense And Amortization Of Long Term Debt Related Party
InterestExpenseAndAmortizationOfLongTermDebtRelatedParty
533000 usd
cccc Interest Expense And Amortization Of Long Term Debt Related Party
InterestExpenseAndAmortizationOfLongTermDebtRelatedParty
1061000 usd
cccc Interest Expense And Amortization Of Long Term Debt Related Party
InterestExpenseAndAmortizationOfLongTermDebtRelatedParty
1067000 usd
CY2022Q2 us-gaap Interest And Other Income
InterestAndOtherIncome
506000 usd
CY2021Q2 us-gaap Interest And Other Income
InterestAndOtherIncome
69000 usd
us-gaap Interest And Other Income
InterestAndOtherIncome
782000 usd
us-gaap Interest And Other Income
InterestAndOtherIncome
141000 usd
CY2021Q2 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-464000 usd
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-279000 usd
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-926000 usd
CY2022Q2 us-gaap Net Income Loss
NetIncomeLoss
-27412000 usd
CY2021Q2 us-gaap Net Income Loss
NetIncomeLoss
-22580000 usd
us-gaap Net Income Loss
NetIncomeLoss
-59032000 usd
us-gaap Net Income Loss
NetIncomeLoss
-43551000 usd
CY2022Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.56
CY2022Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.56
CY2021Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.51
CY2021Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.51
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-1.21
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-1.21
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-1.00
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-1.00
CY2022Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
48823698 shares
CY2022Q2 us-gaap Cash Cash Equivalents And Short Term Investments
CashCashEquivalentsAndShortTermInvestments
397800000 usd
CY2022Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
48823698 shares
CY2021Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
43855420 shares
CY2021Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
43855420 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
48779508 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
48779508 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
43472327 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
43472327 shares
CY2022Q2 us-gaap Marketable Securities Unrealized Gain Loss
MarketableSecuritiesUnrealizedGainLoss
-931000 usd
CY2021Q2 us-gaap Marketable Securities Unrealized Gain Loss
MarketableSecuritiesUnrealizedGainLoss
25000 usd
us-gaap Marketable Securities Unrealized Gain Loss
MarketableSecuritiesUnrealizedGainLoss
-3806000 usd
us-gaap Marketable Securities Unrealized Gain Loss
MarketableSecuritiesUnrealizedGainLoss
-82000 usd
CY2022Q2 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-28343000 usd
CY2021Q2 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-22555000 usd
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-62838000 usd
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-43633000 usd
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
389606000 usd
CY2022Q1 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
260000 usd
CY2022Q1 us-gaap Stock Issued During Period Value Employee Stock Purchase Plan
StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
220000 usd
CY2022Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
8879000 usd
CY2022Q1 us-gaap Marketable Securities Unrealized Gain Loss
MarketableSecuritiesUnrealizedGainLoss
-2875000 usd
CY2022Q1 us-gaap Net Income Loss
NetIncomeLoss
-31620000 usd
CY2022Q1 us-gaap Adjustments To Additional Paid In Capital Other
AdjustmentsToAdditionalPaidInCapitalOther
59000 usd
CY2022Q1 us-gaap Stockholders Equity
StockholdersEquity
364529000 usd
CY2022Q2 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
259000 usd
CY2022Q2 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
8109000 usd
CY2022Q2 us-gaap Marketable Securities Unrealized Gain Loss
MarketableSecuritiesUnrealizedGainLoss
-931000 usd
CY2022Q2 us-gaap Net Income Loss
NetIncomeLoss
-27412000 usd
CY2022Q2 us-gaap Adjustments To Additional Paid In Capital Other
AdjustmentsToAdditionalPaidInCapitalOther
39000 usd
CY2022Q2 us-gaap Stockholders Equity
StockholdersEquity
344593000 usd
CY2020Q4 us-gaap Stockholders Equity
StockholdersEquity
280791000 usd
CY2021Q1 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
166000 usd
CY2021Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
3845000 usd
CY2021Q1 us-gaap Marketable Securities Unrealized Gain Loss
MarketableSecuritiesUnrealizedGainLoss
-107000 usd
CY2021Q1 us-gaap Net Income Loss
NetIncomeLoss
-20971000 usd
CY2021Q1 us-gaap Adjustments To Additional Paid In Capital Other
AdjustmentsToAdditionalPaidInCapitalOther
-19000 usd
CY2021Q1 us-gaap Stockholders Equity
StockholdersEquity
263705000 usd
CY2021Q2 us-gaap Payments Of Stock Issuance Costs
PaymentsOfStockIssuanceCosts
11300000 usd
CY2021Q2 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
169483000 usd
CY2021Q2 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
539000 usd
CY2021Q2 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
5175000 usd
CY2021Q2 us-gaap Marketable Securities Unrealized Gain Loss
MarketableSecuritiesUnrealizedGainLoss
25000 usd
CY2021Q2 us-gaap Net Income Loss
NetIncomeLoss
-22580000 usd
CY2021Q2 us-gaap Adjustments To Additional Paid In Capital Other
AdjustmentsToAdditionalPaidInCapitalOther
80000 usd
CY2021Q2 us-gaap Stockholders Equity
StockholdersEquity
416427000 usd
us-gaap Profit Loss
ProfitLoss
-59032000 usd
us-gaap Profit Loss
ProfitLoss
-43551000 usd
us-gaap Share Based Compensation
ShareBasedCompensation
17086000 usd
us-gaap Share Based Compensation
ShareBasedCompensation
9073000 usd
us-gaap Depreciation
Depreciation
740000 usd
us-gaap Depreciation
Depreciation
839000 usd
us-gaap Operating Lease Right Of Use Asset Amortization Expense
OperatingLeaseRightOfUseAssetAmortizationExpense
2890000 usd
us-gaap Operating Lease Right Of Use Asset Amortization Expense
OperatingLeaseRightOfUseAssetAmortizationExpense
647000 usd
us-gaap Accretion Amortization Of Discounts And Premiums Investments
AccretionAmortizationOfDiscountsAndPremiumsInvestments
-1082000 usd
us-gaap Accretion Amortization Of Discounts And Premiums Investments
AccretionAmortizationOfDiscountsAndPremiumsInvestments
-474000 usd
us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
354000 usd
us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
360000 usd
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-4007000 usd
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
1729000 usd
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-1722000 usd
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
1181000 usd
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-564000 usd
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-1338000 usd
us-gaap Increase Decrease In Accrued Liabilities And Other Operating Liabilities
IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities
-87000 usd
us-gaap Increase Decrease In Accrued Liabilities And Other Operating Liabilities
IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities
316000 usd
us-gaap Increase Decrease In Operating Lease Liability
IncreaseDecreaseInOperatingLeaseLiability
-983000 usd
us-gaap Increase Decrease In Operating Lease Liability
IncreaseDecreaseInOperatingLeaseLiability
-508000 usd
us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
-16006000 usd
us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
-6338000 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-48791000 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-42936000 usd
us-gaap Proceeds From Sale And Maturity Of Marketable Securities
ProceedsFromSaleAndMaturityOfMarketableSecurities
138057000 usd
us-gaap Proceeds From Sale And Maturity Of Marketable Securities
ProceedsFromSaleAndMaturityOfMarketableSecurities
209494000 usd
us-gaap Payments To Acquire Marketable Securities
PaymentsToAcquireMarketableSecurities
108132000 usd
us-gaap Payments To Acquire Marketable Securities
PaymentsToAcquireMarketableSecurities
237622000 usd
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
701000 usd
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
1168000 usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
29224000 usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-29296000 usd
cccc Payments Of Follow On Offering Cost
PaymentsOfFollowOnOfferingCost
10800000 usd
cccc Proceeds From Issuance Of Follow On Offering
ProceedsFromIssuanceOfFollowOnOffering
0 usd
cccc Proceeds From Issuance Of Follow On Offering
ProceedsFromIssuanceOfFollowOnOffering
169934000 usd
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
519000 usd
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
705000 usd
us-gaap Payments For Repurchase Of Initial Public Offering
PaymentsForRepurchaseOfInitialPublicOffering
0 usd
us-gaap Payments For Repurchase Of Initial Public Offering
PaymentsForRepurchaseOfInitialPublicOffering
286000 usd
us-gaap Proceeds From Payments For Other Financing Activities
ProceedsFromPaymentsForOtherFinancingActivities
220000 usd
us-gaap Proceeds From Payments For Other Financing Activities
ProceedsFromPaymentsForOtherFinancingActivities
-3000 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
739000 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
170350000 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
-18828000 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
98118000 usd
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
79403000 usd
CY2020Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
184304000 usd
CY2022Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
60575000 usd
CY2021Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
282422000 usd
CY2022Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
60575000 usd
us-gaap Profit Loss
ProfitLoss
-43600000 usd
CY2021Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
282422000 usd
CY2022Q2 us-gaap Restricted Cash And Cash Equivalents
RestrictedCashAndCashEquivalents
3279000 usd
CY2021Q2 us-gaap Restricted Cash And Cash Equivalents
RestrictedCashAndCashEquivalents
1276000 usd
CY2022Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
57296000 usd
CY2021Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
281146000 usd
us-gaap Interest Paid Net
InterestPaidNet
828000 usd
us-gaap Interest Paid Net
InterestPaidNet
707000 usd
us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
44067000 usd
us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
0 usd
us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
3270000 usd
us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
0 usd
cccc Follow On Costs In Accounts Payable And Accrued Expenses
FollowOnCostsInAccountsPayableAndAccruedExpenses
0 usd
cccc Follow On Costs In Accounts Payable And Accrued Expenses
FollowOnCostsInAccountsPayableAndAccruedExpenses
451000 usd
cccc Aggregate Exercise Price Of Warrant Net Exercised Related Party
AggregateExercisePriceOfWarrantNetExercisedRelatedParty
0 usd
cccc Aggregate Exercise Price Of Warrant Net Exercised Related Party
AggregateExercisePriceOfWarrantNetExercisedRelatedParty
3002000 usd
us-gaap Profit Loss
ProfitLoss
-59000000 usd
CY2022Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-326700000 usd
us-gaap Use Of Estimates
UseOfEstimates
<div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Use of estimates</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The preparation of condensed consolidated financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities as of the date of the condensed consolidated financial statements and the reported amounts of revenues and expenses during the reporting period. The Company bases its estimates and assumptions on historical experience when available and on various factors that it believes to be reasonable under the circumstances. This process may result in actual results differing materially from those estimated amounts used in the preparation of the condensed consolidated financial statements if these results differ from historical experience or other assumptions do not turn out to be substantially accurate, even if such assumptions are reasonable when made. Significant estimates and assumptions reflected in these condensed consolidated financial statements include, but are not limited to, amounts and timing of revenues recognized under the Company’s research and development collaboration arrangements, prepaid and accrued research and development expense, incremental borrowing rate used in the measurement of lease liabilities, and estimated volatility used in fair valuation of stock options. The Company assesses estimates on an ongoing basis; however, actual results could materially differ from those estimates.</span></div>
CY2022Q2 us-gaap Debt Securities Available For Sale Amortized Cost Noncurrent
DebtSecuritiesAvailableForSaleAmortizedCostNoncurrent
345122000 usd
CY2022Q2 cccc Debt Securities Available For Sale Accumulated Gross Unrealized Gain Before Tax Noncurrent
DebtSecuritiesAvailableForSaleAccumulatedGrossUnrealizedGainBeforeTaxNoncurrent
0 usd
CY2022Q2 cccc Debt Securities Available For Sale Accumulated Gross Unrealized Loss Before Tax Noncurrent
DebtSecuritiesAvailableForSaleAccumulatedGrossUnrealizedLossBeforeTaxNoncurrent
4581000 usd
CY2022Q2 us-gaap Available For Sale Securities Debt Securities Noncurrent
AvailableForSaleSecuritiesDebtSecuritiesNoncurrent
340541000 usd
CY2021Q4 us-gaap Debt Securities Available For Sale Amortized Cost Noncurrent
DebtSecuritiesAvailableForSaleAmortizedCostNoncurrent
376130000 usd
CY2021Q4 cccc Debt Securities Available For Sale Accumulated Gross Unrealized Gain Before Tax Noncurrent
DebtSecuritiesAvailableForSaleAccumulatedGrossUnrealizedGainBeforeTaxNoncurrent
1000 usd
CY2021Q4 cccc Debt Securities Available For Sale Accumulated Gross Unrealized Loss Before Tax Noncurrent
DebtSecuritiesAvailableForSaleAccumulatedGrossUnrealizedLossBeforeTaxNoncurrent
776000 usd
CY2021Q4 us-gaap Available For Sale Securities Debt Securities Noncurrent
AvailableForSaleSecuritiesDebtSecuritiesNoncurrent
375355000 usd
CY2022Q2 us-gaap Debt Securities Available For Sale Unrealized Loss Position Number Of Positions
DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions
123 security
CY2022Q2 us-gaap Debt Securities Available For Sale Unrealized Loss Position
DebtSecuritiesAvailableForSaleUnrealizedLossPosition
339111000 usd
CY2022Q2 us-gaap Debt Securities Available For Sale Unrealized Loss Position Accumulated Loss
DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss
4581000 usd
CY2022Q2 cccc Individual Securities
IndividualSecurities
0 usd
CY2022Q2 us-gaap Debt Securities Available For Sale Allowance For Credit Loss
DebtSecuritiesAvailableForSaleAllowanceForCreditLoss
0 usd
CY2021Q4 us-gaap Debt Securities Available For Sale Continuous Unrealized Loss Position12 Months Or Longer Number Of Positions
DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerNumberOfPositions
0 security
CY2022Q2 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
13765000 usd
CY2021Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
10024000 usd
CY2022Q2 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
7428000 usd
CY2021Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
6916000 usd
CY2022Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
6337000 usd
CY2021Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
3108000 usd
CY2022Q2 us-gaap Depreciation
Depreciation
435000 usd
CY2021Q2 us-gaap Depreciation
Depreciation
388000 usd
us-gaap Depreciation
Depreciation
740000 usd
us-gaap Depreciation
Depreciation
839000 usd
CY2021Q2 us-gaap Lease Cost
LeaseCost
765000 usd
us-gaap Lease Cost
LeaseCost
5775000 usd
us-gaap Lease Cost
LeaseCost
1643000 usd
CY2022Q2 us-gaap Lessee Operating Lease Liability Undiscounted Excess Amount
LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
23955000 usd
CY2022Q2 us-gaap Operating Lease Cost
OperatingLeaseCost
2507000 usd
CY2021Q2 us-gaap Operating Lease Cost
OperatingLeaseCost
638000 usd
us-gaap Operating Lease Cost
OperatingLeaseCost
5015000 usd
us-gaap Operating Lease Cost
OperatingLeaseCost
1275000 usd
CY2022Q2 us-gaap Variable Lease Cost
VariableLeaseCost
624000 usd
CY2021Q2 us-gaap Variable Lease Cost
VariableLeaseCost
127000 usd
us-gaap Variable Lease Cost
VariableLeaseCost
972000 usd
us-gaap Variable Lease Cost
VariableLeaseCost
368000 usd
CY2022Q2 us-gaap Sublease Income
SubleaseIncome
212000 usd
CY2021Q2 us-gaap Sublease Income
SubleaseIncome
0 usd
us-gaap Sublease Income
SubleaseIncome
212000 usd
us-gaap Sublease Income
SubleaseIncome
0 usd
CY2022Q2 us-gaap Lease Cost
LeaseCost
2919000 usd
CY2022Q2 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P9Y7M6D
CY2021Q4 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P10Y2M12D
CY2022Q2 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.053
CY2021Q4 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.052
CY2022Q2 us-gaap Lessee Operating Lease Liability Payments Remainder Of Fiscal Year
LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear
4175000 usd
CY2022Q2 us-gaap Lessee Operating Lease Liability Payments Due Next Twelve Months
LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
8571000 usd
CY2022Q2 us-gaap Lessee Operating Lease Liability Payments Due Year Two
LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
8828000 usd
CY2022Q2 us-gaap Lessee Operating Lease Liability Payments Due Year Three
LesseeOperatingLeaseLiabilityPaymentsDueYearThree
9093000 usd
CY2022Q2 us-gaap Lessee Operating Lease Liability Payments Due Year Four
LesseeOperatingLeaseLiabilityPaymentsDueYearFour
9366000 usd
CY2022Q2 cccc Lessee Operating Lease Liability To Be Paid After Year Four
LesseeOperatingLeaseLiabilityToBePaidAfterYearFour
61759000 usd
CY2022Q2 us-gaap Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
101792000 usd
CY2022Q2 cccc Lessee Operating Lease Liability Tenant Improvement Allowance
LesseeOperatingLeaseLiabilityTenantImprovementAllowance
2642000 usd
CY2022Q2 us-gaap Operating Lease Liability
OperatingLeaseLiability
75195000 usd
CY2022Q2 cccc Accrued Research And Development Current
AccruedResearchAndDevelopmentCurrent
8234000 usd
CY2021Q4 cccc Accrued Research And Development Current
AccruedResearchAndDevelopmentCurrent
6863000 usd
CY2022Q2 us-gaap Accrued Employee Benefits Current
AccruedEmployeeBenefitsCurrent
3727000 usd
CY2021Q4 us-gaap Accrued Employee Benefits Current
AccruedEmployeeBenefitsCurrent
5084000 usd
CY2022Q2 cccc Accrued Capital Expenditures Current
AccruedCapitalExpendituresCurrent
2766000 usd
CY2021Q4 cccc Accrued Capital Expenditures Current
AccruedCapitalExpendituresCurrent
0 usd
CY2022Q2 us-gaap Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
947000 usd
CY2021Q4 us-gaap Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
1246000 usd
CY2022Q2 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
1284000 usd
CY2021Q4 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
413000 usd
CY2022Q2 us-gaap Accrued Liabilities And Other Liabilities
AccruedLiabilitiesAndOtherLiabilities
16958000 usd
CY2021Q4 us-gaap Accrued Liabilities And Other Liabilities
AccruedLiabilitiesAndOtherLiabilities
13606000 usd
CY2022Q2 cccc Transaction Price Allocated To Performance Obligation
TransactionPriceAllocatedToPerformanceObligation
67822000 usd
CY2022Q2 cccc Transaction Price Unsatisfied To Performance Obligation
TransactionPriceUnsatisfiedToPerformanceObligation
29310000 usd
CY2022Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
13834000 usd
CY2021Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
9781000 usd
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
21488000 usd
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
17207000 usd
CY2022Q2 us-gaap Receivables Net Current
ReceivablesNetCurrent
1709000 usd
CY2022Q2 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
22170000 usd
CY2022Q2 us-gaap Contract With Customer Liability Noncurrent
ContractWithCustomerLiabilityNoncurrent
17991000 usd
CY2022Q2 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
40161000 usd
CY2021Q4 us-gaap Receivables Net Current
ReceivablesNetCurrent
5716000 usd
CY2021Q4 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
31800000 usd
CY2021Q4 us-gaap Contract With Customer Liability Noncurrent
ContractWithCustomerLiabilityNoncurrent
24368000 usd
CY2021Q4 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
56168000 usd
CY2022Q2 us-gaap Contract With Customer Liability Revenue Recognized
ContractWithCustomerLiabilityRevenueRecognized
12122000 usd
CY2021Q2 us-gaap Contract With Customer Liability Revenue Recognized
ContractWithCustomerLiabilityRevenueRecognized
5535000 usd
us-gaap Contract With Customer Liability Revenue Recognized
ContractWithCustomerLiabilityRevenueRecognized
18488000 usd
us-gaap Contract With Customer Liability Revenue Recognized
ContractWithCustomerLiabilityRevenueRecognized
10054000 usd
CY2022Q2 us-gaap Contract With Customer Performance Obligation Satisfied In Previous Period
ContractWithCustomerPerformanceObligationSatisfiedInPreviousPeriod
503000 usd
CY2021Q2 us-gaap Contract With Customer Performance Obligation Satisfied In Previous Period
ContractWithCustomerPerformanceObligationSatisfiedInPreviousPeriod
713000 usd
us-gaap Contract With Customer Performance Obligation Satisfied In Previous Period
ContractWithCustomerPerformanceObligationSatisfiedInPreviousPeriod
518000 usd
us-gaap Contract With Customer Performance Obligation Satisfied In Previous Period
ContractWithCustomerPerformanceObligationSatisfiedInPreviousPeriod
713000 usd
CY2022Q2 us-gaap Long Term Debt Maturities Repayments Of Principal Remainder Of Fiscal Year
LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear
0 usd
CY2022Q2 us-gaap Long Term Debt Maturities Repayments Of Principal In Next Twelve Months
LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths
3000000 usd
CY2022Q2 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Two
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo
9500000 usd
CY2022Q2 us-gaap Debt Instrument Carrying Amount
DebtInstrumentCarryingAmount
12500000 usd
CY2022Q2 us-gaap Debt Instrument Unamortized Discount Premium And Debt Issuance Costs Net
DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet
1378000 usd
CY2022Q2 us-gaap Long Term Debt
LongTermDebt
11122000 usd
CY2021Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.51
CY2021Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.51
CY2020Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10000000 shares
CY2020Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
150000000 shares
CY2020Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2020Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2020Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2022Q2 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
8148000 usd
CY2021Q2 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
5228000 usd
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
17086000 usd
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
9073000 usd
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 usd
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 usd
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
7055913 shares
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
6150566 shares
CY2022Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.56
CY2022Q2 us-gaap Net Income Loss
NetIncomeLoss
-27412000 usd
CY2021Q2 us-gaap Net Income Loss
NetIncomeLoss
-22580000 usd
us-gaap Net Income Loss
NetIncomeLoss
-59032000 usd
us-gaap Net Income Loss
NetIncomeLoss
-43551000 usd
CY2022Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
48823698 shares
CY2022Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
48823698 shares
CY2021Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
43855420 shares
CY2021Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
43855420 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
48779508 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
48779508 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
43472327 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
43472327 shares
CY2022Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.56
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-1.21
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-1.21
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-1.00
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-1.00

Files In Submission

Name View Source Status
0001628280-22-020886-index-headers.html Edgar Link pending
0001628280-22-020886-index.html Edgar Link pending
0001628280-22-020886.txt Edgar Link pending
0001628280-22-020886-xbrl.zip Edgar Link pending
cccc-20220630.htm Edgar Link pending
cccc-20220630.xsd Edgar Link pending
cccc-20220630xexx311.htm Edgar Link pending
cccc-20220630xexx312.htm Edgar Link pending
cccc-20220630xexx321.htm Edgar Link pending
cccc-20220630xexx322.htm Edgar Link pending
cccc-20220630_cal.xml Edgar Link unprocessable
cccc-20220630_def.xml Edgar Link unprocessable
cccc-20220630_htm.xml Edgar Link completed
cccc-20220630_lab.xml Edgar Link unprocessable
cccc-20220630_pre.xml Edgar Link unprocessable
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending